Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19822982 | 0.89 | CYP1A1 (0.60) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL51622 | 0.84 | ALDH1A1 (0.52) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL14535153 | 0.83 | NPC1 (0.49) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL455156 | 0.83 | HCAR3 (0.55) | MAPTKMT2APOLBGAASMN1; SMN2 | |
| SCHEMBL8418608 | 0.82 | ADRA2A (0.53) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL6776537 | 0.81 | MAPT (0.46) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL10084799 | 0.81 | MAPT (0.52) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL1803092 | 0.81 | ADRA2A (0.53) | MAPTKMT2AMEN1POLBGAA | |
| SCHEMBL10997394 | 0.80 | LMNA (0.56) | MAPTKMT2AMEN1POLBGAA | |
| Oxalic Acid SCHEMBL9716123 | 0.79 | LMNA (0.55) | MAPTKMT2AMEN1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118108-A | Preparation method and application of near infrared nitric oxide probe | 山东第一医科大学(山东省医学科学院) | 2025-06-10 | — | — | CN | disclosed |
| EP-3116935-B1 | NOVEL COVALENTLY CROSS-LINKED MALLEABLE POLYMERS AND METHODS OF USE | UNIV COLORADO REGENTS (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-111778016-B | Near infrared fluorescent probe and preparation method and application thereof | 深圳大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-111978247-B | Two-photon fluorescent probe and preparation method and application thereof | 深圳大学 | 2022-01-25 | — | — | CN | disclosed |
| CN-111978247-A | Two-photon fluorescent probe and preparation method and application thereof | 深圳大学 | 2020-11-24 | — | — | CN | disclosed |
| CN-111778016-A | Near-infrared fluorescent probe and preparation method and application thereof | 深圳大学 | 2020-10-16 | — | — | CN | disclosed |
| US-20170237119-A1 | LI-ION ELECTROLYTE MEMBRANE FACILITATED BY A SELF-HEALING POLYMER MATRIX, AND ASSOCIATED BATTERY | UNIV COLORADO REGENTS (US) | 2017-08-17 | — | — | US | disclosed |
| EP-3116935-A1 | NOVEL COVALENTLY CROSS-LINKED MALLEABLE POLYMERS AND METHODS OF USE | The Regents of the University of Colorado, a body corporate (US) | 2017-01-18 | — | — | EP | disclosed |
| US-9453099-B2 | Covalently cross-linked malleable polymers and methods of use | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-09-27 | — | — | US | disclosed |
| WO-2015138804-A1 | NOVEL COVALENTLY CROSS-LINKED MALLEABLE POLYMERS AND METHODS OF USE | THE REGENTS OF THE UNIVERITY OF COLORADO, A BODY CORPORATE (US) | 2015-09-17 | — | — | WO | disclosed |
| US-7297695-B2 | Pyrrolotriazine compounds as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-11-20 | — | — | US | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| US-20050065246-A1 | Novel azo compound, colorant-containing curable composition, and color filter and method of producing the same | FUJI PHOTO FILM CO., LTD. | 2005-03-24 | — | — | US | disclosed |
| EP-0878196-B1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMA CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6133258-A | PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| EP-0878196-A1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1998-11-18 | — | — | EP | disclosed |
| US-4145363-A | ANTIASTHMATICS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1979-03-20 | — | — | US | disclosed |
| US-4142783-A | Reversible electrochromic display device having memory | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1979-03-06 | — | — | US | disclosed |
| US-4063025-A | PROPHYLAXIS, ANTIASTHMATIC | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SUB1, HYOU1 | MAPT 4884/4885KMT2A 869/4885MEN1 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.